Jump to navigation
Two Phase III trials have shown that IPM’s monthly dapivirine ring can safely help prevent HIV-1 infection in women. Learn more about the results for this innovative product.
Find out how investing in innovative tools to promote women’s sexual and reproductive health is an investment for sustainable development.
Read IPM's latest annual report to learn about progress on our pipeline of HIV and multipurpose prevention products
IPM's CEO talks to Devex about innovative research to address women's HIV prevention needs.
Watch our “Real Voices” videos to hear people working to prevent HIV describe their hopes for how microbicides could help protect women in their communities.